PreveCeutical Medical Inc. (CSE: PREV)

Canada flag Canada · Delayed Price · Currency is CAD
0.0250
+0.0050 (25.00%)
Dec 19, 2024, 9:30 AM EST
0.00%
Market Cap 13.54M
Revenue (ttm) n/a
Net Income (ttm) -1.36M
Shares Out 541.70M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 59,000
Open 0.0250
Previous Close 0.0200
Day's Range 0.0200 - 0.0250
52-Week Range 0.0150 - 0.0300
Beta 0.94
Analysts n/a
Price Target n/a
Earnings Date Apr 25, 2025

About PreveCeutical Medical

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; Non-Addictive Analgesic for pain management; BSV Peptide Program that targets cancer progression; and Dual Gene Therapy for type 2 diabetes and o... [Read more]

Industry Biotechnology
Sector Healthcare
CEO Stephen Van Deventer
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol PREV
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.